AG Oralpathologie DO-087 Detection of human papillomavirus infection in head and neck squamous cell carcinoma J . Dreyer 1 , M . Barros 1 , G . Niedobitek 1 1 Unfallkrankenhaus Berlin, Institute for Pathology, Berlin Aims. A sub-group of head and neck squamous cell carcinoma (HNSCC) is associated with HPV infection, mainly with HPV16. The incidence of this subset has increased and there is evidence to suggest that HPV-positive HNSCC show a more favourable prognosis. There is, however, controversy regarding the most suitable method for the detection of HPV infection in this setting. We have compared HPV DNA in situ hybridisation (ISH) with p16 immunohistochemistry (IHC). Methods. 141 cases of HNSCC diagnosed between 1997 and 2010 were identified. 119 patients (84.4%) were male and 22 (15.6%) were female. Primary site and pTNM stage as well as all other relevant clinicopathological data were extracted from the clinical and pathological files. Primary sites were oropharynx in 65 cases, hypopharynx in 21 cases, floor of mouth in 31 cases, tongue in 20 cases and other sites in the oral cavity in 4 cases. Tissue-micro-arrays (TMA) with three 2 mm cores per case were constructed. IHC for p16 (mtm laboratories) and ISH for high-risk and low-risk HPV-DNA (Ventana) were carried out. Results. 23 cases (16.3%) were positive for p16. Of these, 17 cases (12.1% overall) also showed a nuclear signal for high-risk HPV-DNA by ISH. No p16- cases were positive by ISH and no infection with low-risk HPV types was detected. Thus, there was a statistically significant association of p16 expression and high-risk HPV infection in our series (p
Abstracts the nasopharyngeal tonsil might relate to the anatomical restriction of respiratory surface epithelium to this type of tonsil and might thereby give a clue of the primary site of malignant transformation by EBV. DO-090 Analysis of human papilloma virus (HPV) and Epstein-Barr virus (EBV) in salivary gland adenocarcinomas E . Senft1 , H . Kreipe1 , K . Hussein1 1Hannover Medical School, Institute of Pathology, Hannover Aims. Viruses are known to be associated with neoplastic proliferation, e.g. epitheliotropic human papilloma virus (HPV) can be detected in squamous neoplasms such as cervix carcinoma and oropharynx carcinoma while Epstein-Barr virus (EBV) infects B cells and can induce malignant lymphomas. Furthermore, EBV persists in the ductal epithelial cells of salivary glands and can be associated with solid neoplasms such as benign Warthin tumour. Systematic analyses have been performed in squamous carcinomas of the head and neck but not in salivary gland adenocarcinomas. Methods. Histological re-evaluation and selection of samples: adenoidcyctic carcinomas (n=20), adenocarcinomas, NOS (n=17), mucoepi<strong>der</strong>moid carcinomas (n=11), pleomorphic adenoma (n=4), carcinoma ex pleomorphic adenoma (n=3), non-neoplastic salivary glands (n=65). Analysis of multi-blocks with a total of 120 formalin-fixed and paraffinembedded (FFPE) tissue samples by HPV immunhistochemistry and EBER in situ hybridisation. DNA extraction from FFPE tumour samples and evaluation of HPV by multiplex PCR. Results. HPV and EBV were not detectable in salivary gland carcinomas. Conclusions. This is the first systematic analysis which demonstrates that the two human pathogenic viruses HPV and EBV are not involved in the pathobiology of salivary gland adenocarcinomas. DO-091 SOX2 amplification is a common event in sinunasal squamous cell and undifferentiated carcinomas F . Göke1 , A . Franzen2 , R . Menon2 , S . Huss3 , D . Boehm2 , W . Vogel2 , F . Bootz4 , S . Ihrler5 , A . Schroeck4 , S . Perner1 1 2 3 University Hospital Bonn, Pathology, University Hospital Bonn, University Hospital Cologne, Institute of Pathology, 4University Hospital Bonn, Head and neck department, 5Laboratory for Dermatohistology and Oral Pathology Aims. Although carcinomas of the nasal cavities are known to differ significantly from other cancers of the head and neck, regarding causing noxa, clinical behavior, and treatment, they share histological appearance. SOX2, a transcription factor-coding gene located at 3q26.33, is known to be recurrently amplified in squamous cell carcinomas (SCCs) of the lung, esophagus, skin, penis, cervix uteri and oral cavity. The aim of our study was to assess if SOX2 amplifications also occur in different tumor entities of the paranasal sinuses. Methods. Using fluorescence in-situ hybridization, we assessed for SOX2 amplification status in a cohort consisting of sinonasal SCCs (n=65), sinonasal undifferentiated carcinomas (SNUC, n=18), adenocarcinomas (n=25), and adenoid cystic carcinomas (n=18). Furthermore, we performed SOX2 immunohistochemical staining to quantify protein expression. Results. We detected SOX2 amplifications in 36% of sinunasal SCCs, 35% of SNUCs, 9% of adenocarcinomas, but none of the adenoid cystic carcinomas. Moreover, we found that the SOX2 amplification is associated with a SOX2 protein overexpression in SCCs and SNUCs. Conclusions. SOX2 amplification is not an organ site specific event, but is a frequent genetic alteration occurring in SCCs of various organs. Since SNUCs also harbor SOX2 amplifications in similar frequencies, we 36 | Der Pathologe · Supplement 1 · 2012 hypothesize that SNUCs may be undifferentiated SCCs of the sinunasal cavity. DO-092 Expression of differentiation factor caspase 14 in oral squamous carcinomas C . Scharenberg1 , H . Kreipe1 , K . Hussein1 1Hannover Medical School, Institute of Pathology, Hannover Aims. Caspase 14 is not involved in apoptosis (in contrast to all other caspase family members) but in differentiation of squamous epithelia. Caspase 14 is expressed mainly in the suprabasal layers, particularly the Str. intermedium/spinosum. Systematic analyses have been performed in cervix carcinomas and skin cancer but not oral cavity squamous carcinomas. Methods. Histological re-evaluation and selection of samples: squamous carcinomas of the oral cavity (n=30) and oral leukoplakia (n=10). Caspase 14 expression analysis by immunhistochemical evaluation of formalin fixed and paraffin embedded (FFPE) tissue samples. Results. Nuclear and cytoplasmatic caspase 14 expression is evident in non-neoplastic epithelial cells of the Str. intermedium but absent or weak in the basal and superficial layers. In leukoplakia the protein expression is increased in cells with keratinisation. In invasive lesions, caspase 14 is mainly expressed in the cells with keratinisation but absent or weak in neoplastic cells without keratinisation. Conclusions. This is the first experimental evidence that differentiation factor caspase 14 is expressed in oral cavity squamous carcinomas. Similar to leukoplakia expression of caspase 14 is increased in carcinoma cells with keratinisation. DO-093 FGFR1 amplification in metastatic squamous cell carcinoma of the head and neck – a potential target for a rational therapy? F . Göke1 , A . Franzen2 , R . Menon2 , R . Kirsten2 , D . Boehm2 , W . Vogel2 , F . Bootz3 , A . Schroeck3 , S . Perner1 1 2 3 University Hospital Bonn, Pathology, University Hospital Bonn, University Hospital Bonn, Head and neck department Aims. Currently, patients with FGFR1 amplified squamous cell lung cancers (L-SCC) are treated in phase I clinical trials using small molecule inhibitors. Of interest, SCC of the lung share common molecular alterations with squamous cell head and neck cancers (HN-SCC). Aim of our study is to assess if HN-SCCs also harbor FGFR1 amplifications. Furthermore, we aim to identify a HN-SCC cell line harbouring FGFR1 amplification and inhibit cell proliferation using a small molecule inhibitor. Methods. We put together a cohort of 227 patients suffering from HN- SCC, with 97 of these suffering from metastatic disease. Primary tumors and, where available, metastatic tumors were assessed for FGFR1 copy number status using fluorescence in-situ hybridization (FISH). We tested different cell lines for FGFR1 amplification status and inhibited these with small molecule inhibitors. Results. 20.3% of primary HN-SCC displayed FGFR1 amplifications. Of interest, almost all metastatic tumor samples revealed a FGFR1 amplification if the corresponding primary tumor harbored the amplification. The cell lines HN and SCC-25 harboured FGFR1 amplifications. HN cell proliferation was inhibitable with small molecule inhibitors. Conclusions. FGFR1 amplification frequently occurs in primary and metastatic HN-SCC and proves as a potential target for small molecule therapy in non-operable or metastatic disease. Furthermore, cell growth of FGFR1 amplified cell lines is inhibitable with small molecule inhibitors. Additional functional studies and subsequent clinical trials are needed for further validation of our findings.
- Page 2 and 3: Inhalt Der Pathologe · Supplement
- Page 4 and 5: Inhalt Der Pathologe · Supplement
- Page 6 and 7: Editorial Liebe Kolleginnen und Kol
- Page 8 and 9: Kolorektales Karzinom 2 VO-005 Tran
- Page 10 and 11: Keynote Lecture VO-014 Genetic dete
- Page 12 and 13: (AMACR, FASN, GOLM1, GSP-pi, ERG) t
- Page 14 and 15: to assess the correct rate of R1 re
- Page 16 and 17: DNA damage, and cytotoxic drugs. Au
- Page 18 and 19: HCV-positive formalin-fixed and par
- Page 20 and 21: well as MET activation were examine
- Page 22 and 23: or BRAF mutation, c-MYC and SIRT1 e
- Page 24 and 25: AG Pneumopathologie III DO-032 Remo
- Page 26 and 27: immature granulopoiesis showed a st
- Page 28 and 29: ned, if well-defined mantle zones,
- Page 30 and 31: phomas). Most prominent gains or am
- Page 32 and 33: DO-062 Tumor-associated macrophages
- Page 34 and 35: DO-080 DOG1: an immunohistochemical
- Page 38 and 39: DO-094 Do activated fibroblasts inf
- Page 40 and 41: DO-101 Histopathological analysis o
- Page 42 and 43: DO-108 Identification of potential
- Page 44 and 45: Conclusions. In conclusion, 454 par
- Page 46 and 47: subgroup of patients with B-Raf mut
- Page 48 and 49: DO-002b Impact of terminologies in
- Page 50 and 51: Methods. We performed MCPyV-FISH of
- Page 52 and 53: FR-013 HPV-genotype distribution in
- Page 54 and 55: Methods. Three different techniques
- Page 56 and 57: (i.e. investment in equipment and e
- Page 58 and 59: FR-032 COLD-PCR: a powerful tool in
- Page 60 and 61: dissection (MBLND) technique to imp
- Page 62 and 63: SO-005 Prevalence of mutations in s
- Page 64 and 65: SO-011 Methylation profiling and in
- Page 66 and 67: more effective than SAHA alone and
- Page 68 and 69: SO-022 Specialized pathology review
- Page 70 and 71: SO-027 Ki-67 in mitotic score group
- Page 72 and 73: nificantly associated with advanced
- Page 74 and 75: liver did not correlate with the mu
- Page 76 and 77: AG Paidopathologie II SO-046 Overex
- Page 78 and 79: Results. Histomorphology of the ova
- Page 80 and 81: p42 and p27 have not yet been inves
- Page 82 and 83: SO-068 Recent advances in understan
- Page 84 and 85: SO-075 A novel, dual role of CCN3 i
- Page 86 and 87:
Pancreatic Adenocarcinoma SG-137 Se
- Page 88 and 89:
sease and 30 colon cancer serum sam
- Page 90 and 91:
Conclusions. Although CRC is charac
- Page 92 and 93:
differentiated and TNM stage III or
- Page 94 and 95:
pressed moderate levels of the prot
- Page 96 and 97:
FR-P-037 MALDI imaging reveals COX7
- Page 98 and 99:
in the context of therapy response
- Page 100 and 101:
on primary cells of wild-type and c
- Page 102 and 103:
chemotherapy was recommended and co
- Page 104 and 105:
aims are twofold: 1) to verify the
- Page 106 and 107:
Results. Her2/neu status in TMAs an
- Page 108 and 109:
prognostic impact was found in rect
- Page 110 and 111:
provided information on survival ti
- Page 112 and 113:
Methods. Biopsy specimens from 430
- Page 114 and 115:
the OS rate was 53% for patients wi
- Page 116 and 117:
FR-P-098 Immunohistological stainin
- Page 118 and 119:
FR-P-104 Histopathological evaluati
- Page 120 and 121:
within the earliest morphologic det
- Page 122 and 123:
Conclusions. In primary imaging a g
- Page 124 and 125:
fibrotic neointma development as we
- Page 126 and 127:
FR-P-129 Alpha-1-antitrypsin-PiZ-an
- Page 128 and 129:
FR-P-136 The expression of central
- Page 130 and 131:
cosa and in the periarterial tissue
- Page 132 and 133:
FR-P-149 Combination of Castleman d
- Page 134 and 135:
or without different concentrations
- Page 136 and 137:
Results. In 18 cases (79%) the caus
- Page 138 and 139:
FR-P-168 Autopsy findings in a 2-ye
- Page 140 and 141:
FR-P-174 MPGN-like glomerulonephrit
- Page 142 and 143:
Poster: Gynäkopathologie und Mamma
- Page 144 and 145:
SA-P-011 Genetic aberrations of pre
- Page 146 and 147:
Mechanismen, die eine Progression d
- Page 148 and 149:
internet server. A network of inter
- Page 150 and 151:
Methods. HE-gefärbte Schnittpräpa
- Page 152 and 153:
Conclusions. The newly released 450
- Page 154 and 155:
and desmoplastic reaction are diffe
- Page 156 and 157:
one patient revealed more than 9 mi
- Page 158 and 159:
situation, the V600E mutation in th
- Page 160 and 161:
SA-P-064 Evolution of molecular pat
- Page 162 and 163:
nic markers such as myf4 and MyoD1
- Page 164 and 165:
Conclusions. To our knowledge, this
- Page 166 and 167:
SA-P-085 Expression of the eukaryot
- Page 168 and 169:
Results. The papillary RCC type II
- Page 170 and 171:
SA-P-098 Male infertility: assessme
- Page 172 and 173:
SA-P-104 Process oriented scientifi
- Page 174 and 175:
Conclusions. The IBDW offers a uniq
- Page 176 and 177:
L Lasitschka F. DO-046 Lehmann A. F